S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
China-Based EV Maker BYD Set For Big European, Japanese Expansion
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
An All-In-One Guide for Trading Metals (Ad)pixel
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
China-Based EV Maker BYD Set For Big European, Japanese Expansion
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
An All-In-One Guide for Trading Metals (Ad)pixel
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
China-Based EV Maker BYD Set For Big European, Japanese Expansion
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
An All-In-One Guide for Trading Metals (Ad)pixel
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Sell every Stock except ONE (Ad)
China-Based EV Maker BYD Set For Big European, Japanese Expansion
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Can A.I. Launch You into Your Next Trading Frontier? (Ad)pixel
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
An All-In-One Guide for Trading Metals (Ad)pixel
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Live Updates: Russia-Ukraine War
OTCMKTS:ONPH

Oncology Pharma - ONPH Stock Forecast, Price & News

$0.48
0.00 (0.00%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.48
$0.64
50-Day Range
$0.44
$1.41
52-Week Range
$0.40
$17.70
Volume
39,811 shs
Average Volume
90,447 shs
Market Capitalization
$18.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ONPH stock logo

About Oncology Pharma (OTCMKTS:ONPH) Stock

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Receive ONPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter.

ONPH Stock News Headlines

Oncology Pharma Research and Vision
Oncology Pharma Inc.
See More Headlines
Receive ONPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter.

ONPH Company Calendar

Today
10/04/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ONPH
CIK
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
31,130,000
Market Cap
$18.26 million
Optionable
Not Optionable
Beta
-0.57

Key Executives

  • Mr. Chuck Wagner
    Pres, Treasurer & Chairman
  • Mr. George Malesek
    Interim Chief Exec. Officer
  • Mr. Dimitri Theofilopolous Esq.
    Legal Counsel













ONPH Stock - Frequently Asked Questions

How have ONPH shares performed in 2022?

Oncology Pharma's stock was trading at $4.05 on January 1st, 2022. Since then, ONPH stock has decreased by 88.1% and is now trading at $0.4810.
View the best growth stocks for 2022 here
.

What is Oncology Pharma's stock symbol?

Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPH."

How do I buy shares of Oncology Pharma?

Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oncology Pharma's stock price today?

One share of ONPH stock can currently be purchased for approximately $0.48.

How much money does Oncology Pharma make?

Oncology Pharma (OTCMKTS:ONPH) has a market capitalization of $18.26 million.

How can I contact Oncology Pharma?

Oncology Pharma's mailing address is 16855 WEST BERNARDO DRIVE SUITE 260, SAN DIEGO CA, 92127. The official website for the company is www.oncology-pharma.com. The company can be reached via phone at (415) 869-1038 or via fax at 858-385-8997.

This page (OTCMKTS:ONPH) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.